Table of Contents
ISRN Gastroenterology
Volume 2011, Article ID 206103, 8 pages
http://dx.doi.org/10.5402/2011/206103
Research Article

A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life

1School of Medicine, University of Wales Swansea, Singleton Park, Swansea SA2 8PP, UK
2Clinical Research Unit, Morriston Hospital, Swansea NHS Trust, Swansea SA66NL, UK
3Morriston Hospital, ABM NHS Trust, Swansea SA66NL, UK
4Forever Living Products (UK) Ltd, Warwick, W346RB, UK
5Singleton Hospital, ABM NHS Trust, Swansea SA28QA, UK
6Neath Port Talbot Hospital, ABM NHS Trust, Port Talbot SA127BX, UK

Received 10 September 2010; Accepted 4 October 2010

Academic Editors: Y. Araki and W. A. Meier-Ruge

Copyright © 2011 H. A. Hutchings et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. G. Thompson, G. F. Longstreth, D. A. Drossman, K. W. Heaton, E. J. Irvine, and S. A. Müller-Lissner, “Functional bowel disorders and functional abdominal pain,” Gut, vol. 45, supplement 2, pp. 43–47, 1999. View at Google Scholar · View at Scopus
  2. I. Taneja, K. K. Deepak, G. Poojary, I. N. Acharya, R. M. Pandey, and M. P. Sharma, “Yogic versus conventional treatment in diarrhea-predominant irritable bowel syndrome: a randomized control study,” Applied Psychophysiology Biofeedback, vol. 29, no. 1, pp. 19–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. D. A. Drossman, “The functional gastrointestinal disorders and the Rome II process,” Gut, vol. 45, supplement 2, pp. 1–5, 1999. View at Google Scholar · View at Scopus
  4. D. A. Drossman, Z. Li, E. Andruzzi et al., “U.S. Householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact,” Digestive Diseases and Sciences, vol. 38, no. 9, pp. 1569–1580, 1993. View at Google Scholar · View at Scopus
  5. W. E. Whitehead, C. K. Burnett, E. W. Cook III, and E. Taub, “Impact of irritable bowel syndrome on quality of life,” Digestive Diseases and Sciences, vol. 41, no. 11, pp. 2248–2253, 1996. View at Google Scholar · View at Scopus
  6. F. Creed, J. Ratcliffe, L. Fernandez et al., “Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome,” Annals of Internal Medicine, vol. 134, no. 9, pp. 860–868, 2001. View at Google Scholar · View at Scopus
  7. N. J. Talley, A. R. Zinsmeister, and L. J. Melton III, “Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization,” American Journal of Epidemiology, vol. 142, no. 1, pp. 76–83, 1995. View at Google Scholar · View at Scopus
  8. D. A. Drossman, W. E. Whitehead, and M. Camilleri, “Irritable bowel syndrome: a technical review for practice guideline development,” Gastroenterology, vol. 112, no. 6, pp. 2120–2137, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. W. E. Whitehead, L. Bosmajian, A. B. Zonderman, P. T. Costa Jr., and M. M. Schuster, “Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples,” Gastroenterology, vol. 95, no. 3, pp. 709–714, 1988. View at Google Scholar · View at Scopus
  10. R. C. Smith, D. S. Greenbaum, J. B. Vancouver et al., “Psychosocial factors are associated with health care seeking rather than diagnosis in irritable bowel syndrome,” Gastroenterology, vol. 98, no. 2, pp. 293–301, 1990. View at Google Scholar · View at Scopus
  11. G. Tan, D. C. Hammond, and J. Gurrala, “Hypnosis and irritable bowel syndrome: a review of efficacy and mechanism of action,” American Journal of Clinical Hypnosis, vol. 47, no. 3, pp. 161–178, 2005. View at Google Scholar · View at Scopus
  12. S. K. Hadley and S. M. Gaarder, “Treatment of irritable bowel syndrome,” American Family Physician, vol. 72, no. 12, pp. 2501–2506, 2005. View at Google Scholar · View at Scopus
  13. J. Jailwala, T. F. Imperiale, and K. Kroenke, “Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials,” Annals of Internal Medicine, vol. 133, no. 2, pp. 136–147, 2000. View at Google Scholar · View at Scopus
  14. K. B. Klein, “Controlled treatment trials in the irritable bowel syndrome: a critique,” Gastroenterology, vol. 95, no. 1, pp. 232–241, 1988. View at Google Scholar · View at Scopus
  15. A. Forbes, S. Jackson, C. Walter, S. Quraishi, M. Jacyna, and M. Pitcher, “Acupuncture for irritable bowel syndrome: a blinded placebo-controlled trial,” World Journal of Gastroenterology, vol. 11, no. 26, pp. 4040–4044, 2005. View at Google Scholar · View at Scopus
  16. Y. N. Clement, A. F. Williams, D. Aranda et al., “Medicinal herb use among asthmatic patients attending a specialty care facility in Trinidad,” BMC Complementary and Alternative Medicine, vol. 5, article 3, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. H. L. Smart, J. F. Mayberry, and M. Atkinson, “Alternative medicine consultations and remedies in patients with the irritable bowel syndrome,” Gut, vol. 27, no. 7, pp. 826–828, 1986. View at Google Scholar · View at Scopus
  18. S. C. Kong, D. P. Hurlstone, C. Y. Pocock et al., “The incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases,” Journal of Clinical Gastroenterology, vol. 39, no. 2, pp. 138–141, 2005. View at Google Scholar · View at Scopus
  19. W. M. Gonsalkorale, V. Miller, A. Afzal, and P. J. Whorwell, “Long term benefits of hypnotherapy for irritable bowel syndrome,” Gut, vol. 52, no. 11, pp. 1623–1629, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. P. M. Boyce, N. J. Talley, B. Balaam, N. A. Koloski, and G. Truman, “A randomized controlled trial of cognitive behaviour therapy, relaxation training, and routine clinical care for the irritable bowel syndrome,” American Journal of Gastroenterology, vol. 98, no. 10, pp. 2209–2218, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-G. Grigoleit and P. Grigoleit, “Peppermint oil in irritable bowel syndrome,” Phytomedicine, vol. 12, no. 8, pp. 601–606, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Bensoussan, N. J. Talley, M. Hing, R. Menzies, A. Guo, and M. Ngu, “Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial,” Journal of the American Medical Association, vol. 280, no. 18, pp. 1585–1589, 1998. View at Google Scholar · View at Scopus
  23. D. Grindlay and T. Reynolds, “The Aloe vera phenomenon: a review of the properties and modern uses of the leaf parenchyma gel,” Journal of Ethnopharmacology, vol. 16, no. 2-3, pp. 117–151, 1986. View at Google Scholar · View at Scopus
  24. E. Paulsen, L. Korsholm, and F. Brandrup, “A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris,” Journal of the European Academy of Dermatology and Venereology, vol. 19, no. 3, pp. 326–331, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. B. K. Vogler and E. Ernst, “Aloe vera: a systematic review of its clinical effectiveness,” British Journal of General Practice, vol. 49, no. 447, pp. 823–828, 1999. View at Google Scholar · View at Scopus
  26. J. A. Spanier, C. W. Howden, and M. P. Jones, “A systematic review of alternative therapies in the irritable bowel syndrome,” Archives of Internal Medicine, vol. 163, no. 3, pp. 265–274, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. H. S. Odes and Z. Madar, “A double-blind trial of a celandin, aloevera and psyllium laxative preparation in adult patients with constipation,” Digestion, vol. 49, no. 2, pp. 65–71, 1991. View at Google Scholar · View at Scopus
  28. E. Dimenas, H. Glise, B. Hallerback, H. Hernqvist, J. Svedlund, and I. Wiklund, “Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens?” Scandinavian Journal of Gastroenterology, vol. 28, no. 8, pp. 681–687, 1993. View at Google Scholar · View at Scopus
  29. J. Svedlund, I. Sjodin, and G. Dotevall, “GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease,” Digestive Diseases and Sciences, vol. 33, no. 2, pp. 129–134, 1988. View at Google Scholar · View at Scopus
  30. H.-H. König, A. Ulshöfer, M. Gregor et al., “Validation of the EuroQol questionnaire in patients with inflammatory bowel disease,” European Journal of Gastroenterology and Hepatology, vol. 14, no. 11, pp. 1205–1215, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. N. J. Talley, S. F. Phillips, B. Bruce, C. K. Twomey, A. R. Zinsmeister, and L. J. Melton III, “Relation among personality and symptoms in nonulcer dyspepsia and the irritable bowel syndrome,” Gastroenterology, vol. 99, no. 2, pp. 327–333, 1990. View at Google Scholar · View at Scopus
  32. J. E. Ware Jr., M. Kosinski, and S. D. Keller, “A 12- item short-form health survey: construction of scales and preliminary tests of reliability and validity,” Medical Care, vol. 34, no. 3, pp. 220–233, 1996. View at Google Scholar · View at Scopus
  33. J. E. Ware Jr. and C. D. Sherbourne, “The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection,” Medical Care, vol. 30, no. 6, pp. 473–483, 1992. View at Google Scholar · View at Scopus
  34. C. Jenkinson, R. Layte, D. Jenkinson et al., “A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies?” Journal of Public Health Medicine, vol. 19, no. 2, pp. 179–186, 1997. View at Google Scholar · View at Scopus
  35. B. A. Hahn, L. J. Kirchdoerfer, S. Fullerton, and E. Mayer, “Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life,” Alimentary Pharmacology and Therapeutics, vol. 11, no. 3, pp. 553–559, 1997. View at Google Scholar · View at Scopus
  36. B. A. Hahn, L. J. Kirchdoerfer, S. Fullerton, and E. Mayer, “Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 11, no. 3, pp. 547–552, 1997. View at Google Scholar · View at Scopus
  37. P. Armitage and G. Berry, Statistical Methods in Medical Research, Blackwell, London, UK, 1994.
  38. L. Langmead, R. M. Feakins, S. Goldthorpe et al., “Randomized, double-blind, placebo-controlled trial of oral Aloe vera gel for active ulcerative colitis,” Alimentary Pharmacology and Therapeutics, vol. 19, no. 7, pp. 739–747, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. H. R. Mertz, “Irritable bowel syndrome,” The New England Journal of Medicine, vol. 349, no. 22, pp. 2136–2146, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Lesbros-Pantoflickova, P. Michetti, M. Fried, C. Beglinger, and A. L. Blum, “Meta-analysis: the treatment of irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 20, no. 11-12, pp. 1253–1269, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Camilleri, E. A. Mayer, D. A. Drossman et al., “Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist,” Alimentary Pharmacology and Therapeutics, vol. 13, no. 9, pp. 1149–1159, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. S. A. Müller-Lissner, I. Fumagalli, K. D. Bardhan et al., “Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation,” Alimentary Pharmacology and Therapeutics, vol. 15, no. 10, pp. 1655–1666, 2001. View at Publisher · View at Google Scholar · View at Scopus
  43. E. Ernst and A. Herxheimer, “The power of placebo,” British Medical Journal, vol. 313, no. 7072, pp. 1569–1570, 1996. View at Google Scholar · View at Scopus
  44. T. J. Kaptchuk, “The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance?” Annals of Internal Medicine, vol. 136, no. 11, pp. 817–825, 2002. View at Google Scholar · View at Scopus
  45. T. D. Bolin, “Irritable bowel syndrome,” Australian Family Physician, vol. 34, no. 4, pp. 221–224, 2005. View at Google Scholar · View at Scopus